Strengths

Gross profit margin remains very high at 94.4%, indicating strong product economics.

Current ratio of 4.0 and cash per share of 5.23 provide a solid liquidity cushion.

Revenue per share of 6.33 supports a meaningful top-line base despite losses.

Weaknesses

Profitability remains deeply negative, with net margin at -7.4% and return on equity at -55.8%.

Leverage is elevated, with debt-to-equity at 25.2 and debt-to-assets at 77.2%.

Valuation remains stretched at 9.7x sales and 111.0x free cash flow despite negative earnings.

Opportunities

High gross margins leave room for operating leverage if spending discipline improves.

Strong liquidity could support continued R&D investment and commercialization efforts.

Positive forward PEG of 0.01 suggests the market may be pricing in substantial future growth.

Threats

Interest coverage is negative at -4.3, highlighting ongoing debt-service pressure.

Operating cash flow coverage is only 0.15, leaving limited flexibility if cash generation weakens.

Rich valuation multiples increase downside risk if growth or margin improvement slows.

Overall Score